Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Manousakis

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Physical Review Letters|March 24, 2020
Weak Measurement Protocols for Majorana Bound State IdentificationJ Manousakis, C Wille, A Altland, et al.
American Heart Journal|November 8, 2002
C-reactive protein levels on admission are associated with response to thrombolysis and prognosis after ST-segment elevation acute myocardial infarctionMichael N Zairis, Stavros J Manousakis, Alexander S Stefanidis, et al.
The American Journal of Cardiology|March 5, 2003
C-reactive protein and ST-segment monitoring by continuous 12-lead electrocardiogram in patients with primary unstable angina pectorisMichael N Zairis, John A Ambrose, Olga A Papadaki, et al.
Atherosclerosis|September 3, 2002
C-reactive protein and multiple complex coronary artery plaques in patients with primary unstable anginaMichael N Zairis, Olga A Papadaki, Stavros J Manousakis, et al.
American Heart Journal|March 30, 2006
Continuous 12-lead electrocardiographic ST monitoring and long-term prognosis after successful coronary stentingMichael N Zairis, Stavros J Manousakis, Evdokia N Adamopoulou, et al.
Clinical Cardiology|March 11, 2003
C-reactive protein and rapidly progressive coronary artery disease--is there any relation?Michael N Zairis, Stavros J Manousakis, Alexander S Stefanidis, et al.
Journal of the American College of Cardiology|October 24, 2002
The impact of plasma levels of C-reactive protein, lipoprotein (a) and homocysteine on the long-term prognosis after successful coronary stenting: The Global Evaluation of New Events and Restenosis After Stent Implantation StudyMichael N Zairis, John A Ambrose, Stavros J Manousakis, et al.
Atherosclerosis|September 12, 2006
The impact of hs C-reactive protein and other inflammatory biomarkers on long-term cardiovascular mortality in patients with acute coronary syndromesMichael N Zairis, Evdokia N Adamopoulou, Stavros J Manousakis, et al.
International Journal of Cardiology|April 17, 2007
The impact of circulating total homocysteine levels on long-term cardiovascular mortality in patients with acute coronary syndromesStefanos G Foussas, Michael N Zairis, Stamatis S Makrygiannis, et al.
The American Journal of Cardiology|January 27, 2005
Preprocedural plasma C-reactive protein levels, postprocedural creatine kinase-MB release, and long-term prognosis after successful coronary stenting (four-year results from the GENERATION study)Michael N Zairis, John A Ambrose, Olga Ampartzidou, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Physical Review Letters|March 24, 2020
Weak Measurement Protocols for Majorana Bound State IdentificationJ Manousakis, C Wille, A Altland, et al.
American Heart Journal|November 8, 2002
C-reactive protein levels on admission are associated with response to thrombolysis and prognosis after ST-segment elevation acute myocardial infarctionMichael N Zairis, Stavros J Manousakis, Alexander S Stefanidis, et al.
The American Journal of Cardiology|March 5, 2003
C-reactive protein and ST-segment monitoring by continuous 12-lead electrocardiogram in patients with primary unstable angina pectorisMichael N Zairis, John A Ambrose, Olga A Papadaki, et al.
Atherosclerosis|September 3, 2002
C-reactive protein and multiple complex coronary artery plaques in patients with primary unstable anginaMichael N Zairis, Olga A Papadaki, Stavros J Manousakis, et al.
American Heart Journal|March 30, 2006
Continuous 12-lead electrocardiographic ST monitoring and long-term prognosis after successful coronary stentingMichael N Zairis, Stavros J Manousakis, Evdokia N Adamopoulou, et al.
Clinical Cardiology|March 11, 2003
C-reactive protein and rapidly progressive coronary artery disease--is there any relation?Michael N Zairis, Stavros J Manousakis, Alexander S Stefanidis, et al.
Journal of the American College of Cardiology|October 24, 2002
The impact of plasma levels of C-reactive protein, lipoprotein (a) and homocysteine on the long-term prognosis after successful coronary stenting: The Global Evaluation of New Events and Restenosis After Stent Implantation StudyMichael N Zairis, John A Ambrose, Stavros J Manousakis, et al.
Atherosclerosis|September 12, 2006
The impact of hs C-reactive protein and other inflammatory biomarkers on long-term cardiovascular mortality in patients with acute coronary syndromesMichael N Zairis, Evdokia N Adamopoulou, Stavros J Manousakis, et al.
International Journal of Cardiology|April 17, 2007
The impact of circulating total homocysteine levels on long-term cardiovascular mortality in patients with acute coronary syndromesStefanos G Foussas, Michael N Zairis, Stamatis S Makrygiannis, et al.
The American Journal of Cardiology|January 27, 2005
Preprocedural plasma C-reactive protein levels, postprocedural creatine kinase-MB release, and long-term prognosis after successful coronary stenting (four-year results from the GENERATION study)Michael N Zairis, John A Ambrose, Olga Ampartzidou, et al.
Pageof 2